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Abstract
Background: Risk-appropriate prenatal care has been asserted as a way for the cost-effective delivery of prenatal care. A virtual
care model for prenatal care has the potential to provide patient-tailored, risk-appropriate prenatal educational content and may
facilitate vital sign and weight monitoring between visits. Previous studies have demonstrated a safe reduction in the frequency
of in-person prenatal care visits among low-risk patients but have noted a reduction in patient satisfaction.
Objective: The primary objective of this study was to test the effectiveness of a mobile prenatal care app to facilitate a reduced
in-person visit schedule for low-risk pregnancies while maintaining patient and provider satisfaction.
Methods: This controlled trial compared a control group receiving usual care with an experimental group receiving usual prenatal
care and using a mobile prenatal care app. The experimental group had a planned reduction in the frequency of in-person office
visits, whereas the control group had the usual number of visits. The trial was conducted at 2 diverse outpatient obstetric (OB)
practices that are part of a single academic center in Washington, DC, United States. Women were eligible for enrollment if they
presented to care in the first trimester, were aged between 18 and 40 years, had a confirmed desired pregnancy, were not considered
high-risk, and had an iOS or Android smartphone that they used regularly. We measured the effectiveness of a virtual care platform
for prenatal care via the following measured outcomes: the number of in-person OB visits during pregnancy and patient satisfaction
with prenatal care.
Results: A total of 88 patients were enrolled in the study, 47 in the experimental group and 41 in the control group. For patients
in the experimental group, the average number of in-person OB visits during pregnancy was 7.8 and the average number in the
control group was 10.2 (P=.01). There was no statistical difference in patient satisfaction (P>.05) or provider satisfaction (P>.05)
in either group.
Conclusions: The use of a mobile prenatal care app was associated with reduced in-person visits, and there was no reduction
in patient or provider satisfaction.
Trial Registration: ClinicalTrials.gov NCT02914301; https://clinicaltrials.gov/ct2/show/NCT02914301 (Archived by WebCite
at http://www.webcitation.org/76S55M517)
(JMIR Mhealth Uhealth 2019;7(5):e10520)   doi:10.2196/10520
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Introduction
Background
In the United States, there are nearly 4 million live births each
year. This makes prenatal care one of the most widely utilized
preventative care health services [1,2]. Despite its widespread
use, the effectiveness and organization of standard prenatal care
has been debated [3-5]. Rigorous scientific evidence of the
effectiveness of standard prenatal care, including effects on
maternal and infant outcomes, health-related behaviors, and
health care costs is limited [2]. In the early mid-1980s, an expert
panel recommended stratifying women into high- and low-risk
categories, with high-risk women receiving more intensive
prenatal care and low-risk women following a reduced visit
frequency schedule [6]. The rationale for this recommendation
was that unnecessary visits for low-risk patients consume health
care resources that could be applied more judiciously to women
with higher-risk pregnancies. However, despite these
recommendations, the standard model of prenatal care with
high-frequency visits has persisted. Almost a third of low-risk
women receive more visits than recommended by the American
College of Obstetricians and Gynecologists (ACOG) [7]. The
barriers cited by providers for not reducing visits for low-risk
pregnancies include the following: concern about decreased
patient satisfaction, need for frequent weight and blood pressure
monitoring, and concern about reduced transmission of
educational information regarding health and lifestyle choices
during pregnancy.
Goal of This Study
The primary objective of this study was to determine if a mobile
prenatal care app facilitates a reduced in-person prenatal care
visit schedule while maintaining patient and provider
satisfaction. Mobile health apps have the potential to address
many of the perceived barriers to reducing in-person visits [8].
The application of mobile phone technology has been shown
to improve disease management for diabetes self-care activities,
HIV infection medication adherence, and sickle cell anemia
medication adherence [9-11]. We hypothesize that a similar
approach using a mobile app and connected monitoring devices
may also be beneficial to manage prenatal care. A pilot trial
with 8 patients was performed. This trial ensured the platform
and devices functioned appropriately, any blood pressure and
weight triggers were identified and managed, a reduced visit
schedule was achieved on a small scale, and the platform was
satisfactory to patients. The feedback from the pilot guided this
investigation [12].
Methods
Study Design
This pragmatic controlled trial compared an experimental group
that received a mobile app for prenatal care and an integrated
Wi-Fi-connected blood pressure and weight scale with a control
group that received usual care. Institutional Review Board (IRB)
approval has been obtained from the George Washington
University (GWU) IRB (IRB#: 015422).
Study Setting
The educational components and clinical triggers were
developed and refined at GWU in Washington, DC, United
States, working in conjunction with a local mobile health
technology firm 1EQ and their product Babyscripts [13]. The
clinical trial occurred in 2 obstetric (OB) and gynecology (GYN)
offices in the United States: one in downtown Washington, DC,
and one in suburban Maryland. Prenatal care is provided at both
locations by OB and GYN physicians and nurse midwives.
Low-risk women are cared for by obstetrician-gynecologists at
both locations, and all deliveries take place at the GWU hospital
in Washington, DC. Enrollment occurred between July 2015
and March 2016.
Inclusion and Exclusion Criteria
Eligible participants were women aged between 18 and 40 years,
presenting for a first trimester (up to 13 weeks gestational age)
verification of pregnancy or new OB visit, and who were
considered low-risk. Low-risk was defined as a singleton
pregnancy with no previous diagnosis of essential hypertension,
diabetes, renal disease, collagen vascular disease, maternal
substance abuse, or other previously documented condition
posing a high risk of poor pregnancy outcome. Dropout criteria
for the study included the antepartum diagnosis of fetal
abnormalities, placenta previa, intrauterine growth restriction,
pregnancy-induced hypertension, gestational diabetes, or
premature rupture of membranes. (Multimedia Appendix 1)
Participants were also required to regularly use a mobile phone
and be fluent in English.
Allocation
Allocation into the experimental group versus the control group
was based on the operating system of the patient’s mobile phone.
Patients with iOS-based mobile phones (ie, iPhones) were
allocated to the experimental group; patients with Android or
Windows operating systems were allocated to the control group.
This allocation system was chosen as a practical solution to the
challenges of randomization and blinding. In addition, the app
had yet to be developed on the Android platform. Allocation
was concealed until after consent was obtained.
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Table 1. Sample alternative prenatal care schedules.
Total visitsWeek numberNew OBa
visit
Schedule
403938373634323028242016
131111111111111Traditional prenatal care
schedule (1=visit)
91110101011011Babyscripts prenatal care
schedule (0=no visit, 1=visit)
aOB: obstetric.
Study Arms
Participants who were assigned to the experimental group were
instructed to download the mobile app and set up the connected
monitoring devices at the time of enrollment. Participants
incurred no additional costs for the app or connected devices.
Participants allocated to the control arm were not given access
to the mobile app. The experimental group was also placed on
an alternative prenatal care schedule of 8 expected visits as
compared with the typical 12-14 expected visits in the control
group (Table 1). The experimental visit schedule was based on
the Department of Defense-Veterans Affairs Uncomplicated
Pregnancy Guidelines [14]. For all participants, prenatal care
met established guidelines for the management of uncomplicated
pregnancies.
Data Collection
Patient demographics were obtained by self-report at the time
of enrollment. Detailed patient characteristics were also collected
at the time of enrollment, including age, race, insurance status,
and ethnicity. The primary outcome of the study was the number
of in-person prenatal care visits as assessed by patient chart
review. As a secondary outcome, all patients were evaluated
for satisfaction with their prenatal care experience and pregnancy
outcomes. (Multimedia Appendix 2) Patient satisfaction surveys
were administered to participants at gestational weeks 16, 20,
25, 30, and 35 and 2 weeks postpartum. Satisfaction survey
consisted of 16 questions using a 4-point Likert scale modified
from the hospital consumer assessment of health care providers
and systems survey instrument [15] In addition, 6 questions
specific to the Babyscripts platform were submitted to
participants in the experimental group. Participants who
completed all 6 surveys and responded to all related
questionnaires were compensated with a US$20 Amazon gift
card at completion of the study. An additional secondary
outcome was obtained via a chart review for significant clinical
outcomes—preeclampsia, eclampsia, neonatal intensive care
unit admissions, stillbirth, neonatal mortality, other serious
outcome per investigator judgment, and route of delivery
including cesarean delivery rate. Chart reviews were completed
using trained abstractors with defined data collection sheets.
Statistical Analysis
We compared outcomes between study arms using t tests for
continuous outcomes and chi-square tests for dichotomous
outcomes. For differences in the baseline characteristics between
the 2 study groups, we used a hierarchical generalized logistic
or linear regression model that includes an indicator for the
study arm. We conducted descriptive heterogeneity of treatment
effect analyses by age, gender, race/ethnicity, and highest
attained maternal education level.
Description of Mobile App
The Babyscripts app was designed with 2 major goals: (1) to
deliver educational content via a mobile app and (2) to remotely
monitor blood pressure and weight. The educational content
was based upon ACOG standards and refined by a committee
of 4 board-certified obstetricians at the GWU School of
Medicine. Input from a variety of other stakeholders including
patients, midwives, and administrators was also obtained. The
mobile app sends educational content to the expectant mother
at gestation-appropriate times throughout the pregnancy. This
information encompasses material covering pregnancy
progression; preexisting risk hazards such as alcohol intake,
smoking, or drug abuse; advice to address these risk hazards;
dietary and nutritional content; breastfeeding information;
guidelines for appropriate weight gain; and warning signs for
pregnancy complications. In addition, the app integrates with
a Wi-Fi-connected scale and blood pressure cuff to provide both
feedback and alerts depending on the readings. The alerts were
created to provide early warnings to patients and providers about
aberrant data points with the hope of providing early detection
of hypertensive disorders of pregnancy and abnormal weight
gain, indicating an increased risk of gestational diabetes,
nutritional deficiency, or edema associated with preeclampsia.
Results
User Statistics
A total of 181 women met the inclusion criteria and were
screened for enrollment. Of those, 118 met screening criteria
and agreed to participate. Furthermore, 60 women were allocated
to the experimental group and 58 women were allocated to the
control group (Figure 1). Of those, 13 participants in the
experimental group and 17 in the control group discontinued
involvement in the study because they transferred care (n=11),
developed high-risk characteristics (n=7), experienced a
miscarriage (n=5), requested to no longer participate (n=2), or
other reasons (n=5). Ultimately, 47 participants in the
experimental group and 41 in the control group were retained
in the study until completion and were analyzed. There was no
significant difference in baseline characteristics (Table 2).
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Figure 1. CONSORT flow diagram.
Table 2. Patient characteristics and number of visits per group.
Standard care (n=41)Babyscripts (n=47)Characteristics
32.2 (3.2)33.0 (3.3)Age at screening (years), mean (SD)
24.9 (4.0)22.9 (3.2)Body mass index at screeninga, mean, kg/m2, (SD)
13 (32)14 (30)African-American, n (%)
3 (7)3 (6)Hispanic, n (%)
36 (88)45 (96)College graduate, n (%)
Gravidity per patient, n (%)
22 (53)25 (53)One
19 (46)22 (47)Greater than one
Parity per patient, n (%)
25 (61)30 (64)Zero
16 (39)17 (36)Greater than one
10.2 (1.8)7.9 (1.8)Number of in-person prenatal care visitsa, mean (SD)
aP<.001.
Evaluation Outcomes
The experimental group had significantly fewer prenatal care
visits (7.9 visits) than patients in the control group (10.2 visits;
P=.01 Table 2; Figure 2). Patient satisfaction measured over
several intervals demonstrated no difference in satisfaction
between the experimental and control group. Satisfaction scores
were aggregated for all 16 questions that were asked to
participants in both the control and experimental groups at each
time point during gestation. For data visualization, the scores
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were normalized from 0 to 1 and then compared for statistical
differences at each time point. Provider surveys demonstrated
aggregate scores demonstrating highly perceived quality and
satisfaction with the virtual care platform. There was no
statistical difference in patient satisfaction (P>.05) or provider
satisfaction (P>.05) in either group (Figure 3).
Although maternal and fetal outcomes were tracked, the study
was not powered to demonstrate the effect of the virtual care
platform on maternal or fetal outcomes. We identified 1 adverse
fetal event of stillbirth at 38 weeks gestation. Investigation of
the case revealed that the patient had an uncomplicated
pregnancy and was compliant with the prenatal care schedule
of the experimental group. Her obstetrician saw her in person
within 3 days of the fetal demise at which time normal fetal
movement and fetal heart tones were identified. Workup
revealed a likely fetal-maternal hemorrhage unrelated to the
study protocol.
Figure 2. Total number of prenatal clinical visits per group. Babyscripts (Brx) versus controls. P value is based on Wilcoxon ranked-sum test.
Figure 3. Survey data for patient satisfaction with overall prenatal care between Babyscripts (Brx) and control groups. For each time point, Brx and
control patients are given a survey. The total numeric scores for all questions at that time point is calculated. All numeric scores are then normalized to
1 to standardize between different numbers of survey questions. SOC: standard of care.
Discussion
Principal Findings
Pregnant women represent a promising target for digital health
apps. Unlike digital health apps that target chronically ill or
elderly populations, pregnant women are a young and healthy
population. A mobile health app that targets pregnant women
may facilitate the integration of prenatal care into other aspects
of their family and professional life. In addition, pregnancy is
a unique period of life when healthy behaviors including
exercise, diet, and sleep take on greater importance. As such,
women are highly engaged with their health care decisions
during pregnancy and may be more receptive to educational
programs that can be delivered through a mobile health app.
Finally, the majority of prenatal care visits are scheduled to
exchange educational information with the patient or weight
and blood pressure data with the provider. Both of these
exchanges are especially amenable to communication via mobile
technology or remote monitors. Ultimately, the app does not
replace in-person visits but may replace some of the current
activities that occur at each visit. If the app can communicate
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basic educational components of prenatal care, the in-person
visits may allow for more individualized discussions.
As part of this study, several important elements emerged as
critical to the success of a mobile prenatal care app. First, the
initial assessment is critical to identifying high-risk versus
normal-risk on initial assessment; second, accurate
communication of patient data to the provider is necessary to
assess early signs of pregnancy complications; third, educational
information must be provided at the appropriate time during
pregnancy; fourth, educational information should be targeted
to individual patient (eg, not all women need regular reminders
about the importance of smoking cessation); and fifth, a clear
explanation that the role of the mobile app is to augment and
not replace the obstetrician or midwife.
Limitations
There are several limitations to our study. First, the use of a
quasi-randomization scheme where participants were allocated
by type of phone creates potential confounders, as it is possible
that iOS users differ from non-iOS users. However, there was
no significant difference in age, race, education level, gravity,
or parity between the cohorts. We did not collect data on
differences in household income, a possible confounder. The
second risk concerns the possibility of contamination across
groups. It is possible that by reducing visits in the experimental
group, physicians were more likely to reduce the visits in all
patients. However, given there was a statistically significant
difference in visit schedule, this was unlikely to confound this
cohort. Third, the mobile prenatal care app was prescribed as
part of the reduced care schedule, and it is unknown if a reduced
care schedule might have been effective without the mobile care
app or with a different solution. Finally, we have limited
information regarding emergency visits or phone calls that may
have occurred outside of the chart review or the direct patient
calls. It is possible that there were some therapeutic interactions
missed in both the control and experimental group.
Conclusions
In conclusion, satisfaction was unchanged and visits were
reduced through the use of the prenatal mobile care app,
Babyscripts. Future studies will look for predictors of adverse
clinical outcomes in a variety of populations in hopes of
mitigating risk of adverse events.
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